MeSH term
Frequency | Condition_Probility | Humans | 41 | 0.0 |
Animals | 14 | 0.0 |
Cells, Cultured | 12 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Homocysteine/pharmacology | 2 | 40.0 |
Mice | 7 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 25 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Tumor Cells, Cultured | 15 | 0.0 |
Base Sequence | 9 | 0.0 |
Cell Line | 7 | 0.0 |
DNA Primers | 5 | 0.0 |
Gelatinase A/*genetics | 2 | 22.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Radiation, Ionizing | 2 | 1.0 |
Trans-Activation (Genetics)/*physiology | 2 | 1.0 |
Transcription Factors/*physiology | 4 | 0.0 |
*Apoptosis | 2 | 0.0 |
Enzyme Activation | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 4 | 0.0 |
MAP Kinase Signaling System | 2 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Mutation | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 8 | 1.0 |
Disease Models, Animal | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Male | 4 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Promoter Regions (Genetics) | 12 | 0.0 |
Rats | 5 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Homeostasis | 2 | 0.0 |
Amino Acid Chloromethyl Ketones/pharmacology | 2 | 1.0 |
Apoptosis/*drug effects | 2 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Transfection | 7 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
*Oligonucleotide Array Sequence Analysis | 2 | 1.0 |
RNA, Messenger/genetics | 3 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Leucine Zippers | 4 | 2.0 |
Open Reading Frames | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Blotting, Western | 4 | 0.0 |
Prognosis | 2 | 0.0 |
Transcription Factors/*biosynthesis | 2 | 1.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Luciferases/genetics | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
Response Elements/genetics | 2 | 1.0 |
Transcription, Genetic/*drug effects | 2 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Binding Sites | 4 | 0.0 |
Hela Cells | 4 | 0.0 |
TATA Box | 2 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
Stress/genetics/*metabolism | 2 | 22.0 |
Comparative Study | 2 | 0.0 |
Methyl Methanesulfonate/pharmacology | 2 | 5.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Ultraviolet Rays | 3 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Gene Expression/*drug effects | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Exons | 2 | 0.0 |
Plasmids | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
*Gene Expression | 2 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Transcription Factors/biosynthesis/*metabolism | 2 | 4.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
Models, Genetic | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Time Factors | 4 | 0.0 |
Kinetics | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
